Related Experiment Video
Updated: Aug 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Vaccines for measles, mumps and rubella in children
V Demicheli1, T Jefferson, A Rivetti
1Servizo Sovrazonale di Epidemiologia, ASL 20, Via Venezia 6, Alessandria, Piemonte, Italy 15100. demichelivittorio@asl20.piemonte.it
Background:
Public debate over the safety of the trivalent measles, mumps and rubella (MMR) vaccine, and the resultant drop in vaccination rates in several countries, persists despite its almost universal use and accepted effectiveness.
Objectives:
We carried out a systematic review to assess the evidence of effectiveness and unintended effects associated with MMR.
Search Strategy:
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 4, 2004), MEDLINE (1966 to December 2004), EMBASE (1974 to December 2004), Biological Abstracts (from 1985 to December 2004), and Science Citation Index (from 1980 to December 2004). Results from reviews, handsearching and from the consultation of manufacturers and authors were also used.
Selection Criteria:
Eligible studies were comparative prospective or retrospective trials testing the effects of MMR compared to placebo, do-nothing or a combination of measles, mumps and rubella antigens on healthy individuals up to 15 years of age. These studies were carried out or published by 2004.
Data Collection And Analysis:
We identified 139 articles possibly satisfying our inclusion criteria and included 31 in the review.
Main Results:
MMR was associated with a lower incidence of upper respiratory tract infections, a higher incidence of irritability, and similar incidence of other adverse effects compared to placebo. The vaccine was likely to be associated with benign thrombocytopenic purpura, parotitis, joint and limb complaints, febrile convulsions within two weeks of vaccination and aseptic meningitis (mumps) (Urabe strain-containing MMR). Exposure to MMR was unlikely to be associated with Crohn's disease, ulcerative colitis, autism or aseptic meningitis (mumps) (Jeryl-Lynn strain-containing MMR). We could not identify studies assessing the effectiveness of MMR that fulfilled our inclusion criteria even though the impact of mass immunisation on the elimination of the diseases has been largely demonstrated.
Authors' Conclusions:
The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate. The evidence of adverse events following immunisation with MMR cannot be separated from its role in preventing the target diseases.
Insights
The measles, mumps, and rubella (MMR) vaccine is linked to fewer respiratory infections but may cause irritability and certain adverse events. Evidence suggests MMR is unlikely to cause autism or inflammatory bowel disease.
Area of Science:
- Immunology and Vaccinology
- Public Health
- Pediatric Medicine
Background:
- Ongoing public debate regarding the safety of the measles, mumps, and rubella (MMR) vaccine.
- Declining vaccination rates in some countries despite the vaccine's widespread use and efficacy.
- Need for a comprehensive review of MMR vaccine safety and effectiveness.
Purpose of the Study:
- To systematically review the evidence on the effectiveness of the MMR vaccine.
- To assess unintended effects and adverse events associated with MMR vaccination.
- To evaluate the association between MMR vaccine and specific health outcomes.
Main Methods:
- Conducted a systematic literature search across multiple databases (CENTRAL, MEDLINE, EMBASE, etc.) up to December 2004.
- Included comparative prospective or retrospective trials of MMR vaccine versus placebo or no intervention in individuals up to 15 years of age.
- Analyzed data from 31 eligible studies out of 139 initially identified articles.
Main Results:
- MMR vaccination was associated with reduced incidence of upper respiratory tract infections and increased irritability.
- Potential associations found with benign thrombocytopenic purpura, parotitis, joint complaints, febrile convulsions, and aseptic meningitis (Urabe strain).
- MMR vaccination (Jeryl-Lynn strain) was unlikely associated with Crohn's disease, ulcerative colitis, autism, or aseptic meningitis.
Conclusions:
- The reporting and design of safety outcomes in MMR vaccine studies are largely insufficient.
- Separating the adverse events from the disease-preventing benefits of the MMR vaccine is challenging.
- Further high-quality research is needed to adequately assess MMR vaccine safety.
Related Concept Videos
Respiratory Syncytial Virus Disease
Vaccinations
Microorganisms in Medicine and Therapeutics
Poliomyelitis
Vaccines
Smallpox

